Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

The treatment was not recommended due to limited effectiveness and significant side effects.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

CS12192 effectively treats alopecia areata with better safety than current options.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Apremilast showed mixed results for treating severe alopecia areata.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.